Prof Petrylak speaks with ecancer at ESMO 2017 about the combination of docetaxel and ramucirumab, a targeted therapy against VEGFR2, to treat metastatic urothelial carcinoma. He describes the angiogenic control of the added antibody leading to a doubled...
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2wQPGTA
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,